Yiannis Monovoukas

Yiannis A. Monovoukas is the founder of SpringTide Capital Management LLC (founded in 2018) where he serves as an Investment Committee Advisor, Falcon III Ventures GP LLC (founded in 2018) where he is the Managing Partner, and AuraGen Aesthetics LLC (founded in 2016) where he holds the position of Chief Executive Officer.
Dr. Monovoukas currently holds the position of Non-Executive Director at Owlstone, Inc., Director at Benefits Science LLC (since 2018), Director at Pathology Watch, Inc., and Director at AEYE Health LLC.
Dr. Monovoukas has previously worked as the President & Chief Executive Officer of Thermo Fibergen, Inc. (1996-2010), Chairman, President & Chief Executive Officer of TEI Biosciences, Inc., and as a Director at Ovation Products Corp.
He also worked as a Business Analyst at Thermo Electron Corp.
in 1996.
Dr. Monovoukas has an undergraduate degree from The Trustees of Columbia University in The City of New York, an MBA from Harvard University, and graduate and doctorate degrees from Stanford University.